The weekly litigation news digest is live. Subscribe now

Patent Oppositions in vaccines and immunity drugs industry

Explore the competitive field of vaccines and immunity drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in vaccines and immunity drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the vaccines and immunity drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the vaccines and immunity drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jan 1, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
Rsv Immunization RegimenGLAXOSMITHKLINENov 26, 2025PFIZER
Virus-Like Particle (Vlp)PHARMAQNov 19, 2025INTERVET
Liquid Antibody FormulationICHNOS SCIENCESNov 5, 2025J A KEMP
Liquid Antibody FormulationICHNOS SCIENCESNov 3, 2025SANOFI
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEOct 29, 2025STORZ
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEOct 28, 2025J A KEMP
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEOct 23, 2025BRAND MURRAY FULLER
Method And Compositions For Cellular ImmunotherapyFRED HUTCHINSON CANCER RESEARCH CENTEROct 8, 2025BOULT WADE TENNANT
Engineered Gamma Delta T-CellsADICET THERAPEUTICSSep 25, 2025STRAWMAN

To stay ahead in the competitive vaccines and immunity drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the vaccines and immunity drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jan 1, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFER10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY10
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
Sep 11, 2019Binding Molecules For Bcma And Cd3AMGEN8
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS7
Jan 3, 2024Method For Producing Rna CompositionsCUREVAC7
Aug 21, 2019Binding Molecules For Bcma And Cd3BOEHRINGER INGELHEIM7
Feb 26, 2020Toxicity Management For Anti-Tumor Activity Of CarsTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA7
Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerPFIZER7